Open AccessS0795 Outcomes Combining Vedolizumab With Other Biologics or With Tofacitinib to Treat Inflammatory Bowel Disease
Author(s) -
Ernesto M. Llano,
Shreeju Shrestha,
Moheb Boktor,
David Fudman
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000705228.65225.7f
Subject(s) - medicine , vedolizumab , tofacitinib , adalimumab , inflammatory bowel disease , ulcerative colitis , ustekinumab , combination therapy , gastroenterology , infliximab , calprotectin , surgery , disease , rheumatoid arthritis